Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

STEP Ezine
Table of Contents, May 19, 2000


Special Points of Interest:

  • What are the recommended dosing levels for NRTIs?

  • What are the common side effects?

    Advertisement

  • What are the more serious side effects?

Learn about this and more in this issue of the Ezine.


Special thanks to the following for contributing written material to this publication:

  • STEP Publications Advisory Committee
  • Brian Coppedge, Sr. Treatment Educator
  • Dupont Pharmaceuticals
  • The Washington State Department of Health

STEP reviews a wide spectrum of HIV treatment options but does not endorse any particular treatment, product, company, or individual. Participation in the preparation of the materials included in the Ezine does not imply endorsement by any of the individuals who have contributed to its production.

STEP Ezine is a publication of the Seattle Treatment Education Project copyright 2000. Permission required for republishing articles (and gladly given in most circumstances).




  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Seattle Treatment Education Project. It is a part of the publication STEP Ezine.
 

Tools
 

Advertisement